<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766584</url>
  </required_header>
  <id_info>
    <org_study_id>0201085</org_study_id>
    <secondary_id>DGS 2003/0069</secondary_id>
    <nct_id>NCT00766584</nct_id>
  </id_info>
  <brief_title>Autonomic Nervous System Activity, Aging and Sleep Apnea/Hypopnea</brief_title>
  <acronym>SYNAPSE</acronym>
  <official_title>Autonomic Nervous System Activity, Aging and Sleep Apnea/Hypopnea in a Prospective Cohort of Subjects Aged 67 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The regulatory effects of the autonomic nervous system (ANS) concern almost all organs which
      permanently feed information back to this global biological vigilance system controlling
      allostasis. Heart rate fluctuations are highly dependent on ANS control, making the heart one
      of the best indicators of ANS activity.

      Low ANS activity level is associated with severe cardiac and cerebral events, as well as to
      death from any cause in the general population. It is even associated with sleep
      apnea/hypopnea.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main goal of this SYNAPSE study is to evaluate, on a selected prospective cohort of
      subjects aged 67 years upon study entry, the incidence of sleep apnea/hypopnea and the
      prognostic values of ANS activity levels measured at preset times and of cardiovascular or
      cerebrovascular events.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 15, 2003</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite criterion : fatal and non-fatal cardiovascular or cerebrovascular events</measure>
    <time_frame>During all the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence and relationship of sleep apnea/hypopnea and clinically silent stroke revealed through brain MRI</measure>
    <time_frame>Years 1, 3, 5, 7 and 9</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">852</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>PROOF cohort</arm_group_label>
    <description>This cohort is the same than the PROOF study (NCT00759304). Subjects were recruited amongst the inhabitants of the city of Saint-Etienne, France, and were eligible if aged 65 at the inclusion date in the PROOF study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sleep apnea/hypopnea detection</intervention_name>
    <description>Simultaneous 24-hour ambulatory electrocardiogram and polygraphic recordings performed at home during a night.</description>
    <arm_group_label>PROOF cohort</arm_group_label>
    <other_name>HypnoPTT, Tyco Healthcare, USA</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects were recruited amongst the inhabitants of the city of Saint-Etienne, France, and
        were eligible if aged 65 at the inclusion date in the PROOF study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent signed

          -  to participate in the PROOF study

        Exclusion Criteria:

          -  prior myocardiac infarction

          -  prior stroke

          -  hearth failure

          -  atrial fibrillation

          -  insulin-treated diabetes mellitus

          -  cardiac pacemaker

          -  disease limiting life expectancy to &lt; 5 years

          -  contraindication to brain MRI

          -  living in an institution

          -  respiratory failure with oxygenotherapy

          -  sleep-related breathing disorders known and treated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>67 Years</minimum_age>
    <maximum_age>68 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Claude BARTHELEMY, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier de Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994 Aug;90(2):878-83.</citation>
    <PMID>8044959</PMID>
  </reference>
  <reference>
    <citation>Pitson DJ, Stradling JR. Autonomic markers of arousal during sleep in patients undergoing investigation for obstructive sleep apnoea, their relationship to EEG arousals, respiratory events and subjective sleepiness. J Sleep Res. 1998 Mar;7(1):53-9.</citation>
    <PMID>9613428</PMID>
  </reference>
  <reference>
    <citation>Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53.</citation>
    <PMID>15781100</PMID>
  </reference>
  <reference>
    <citation>Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J. 2005 Mar;25(3):514-20.</citation>
    <PMID>15738297</PMID>
  </reference>
  <results_reference>
    <citation>Barthélémy JC, Pichot V, Dauphinot V, Celle S, Laurent B, Garcin A, Maudoux D, Kerleroux J, Lacour JR, Kossovsky M, Gaspoz JM, Roche F. Autonomic nervous system activity and decline as prognostic indicators of cardiovascular and cerebrovascular events: the 'PROOF' Study. Study design and population sample. Associations with sleep-related breathing disorders: the 'SYNAPSE' Study. Neuroepidemiology. 2007;29(1-2):18-28.</citation>
    <PMID>17898520</PMID>
  </results_reference>
  <results_reference>
    <citation>Celle S, Peyron R, Faillenot I, Pichot V, Alabdullah M, Gaspoz JM, Laurent B, Barthélémy JC, Roche F. Undiagnosed sleep-related breathing disorders are associated with focal brainstem atrophy in the elderly. Hum Brain Mapp. 2009 Jul;30(7):2090-7. doi: 10.1002/hbm.20650.</citation>
    <PMID>18781591</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2008</study_first_submitted>
  <study_first_submitted_qc>October 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2008</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>Autonomic nervous system</keyword>
  <keyword>stroke</keyword>
  <keyword>Myocardiac infarction</keyword>
  <keyword>Prospective cohort</keyword>
  <keyword>Sleep apnea/hypopnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

